Search research articles
Contact Us
Filters
Showing results (271-280 of 332) with videos related to
Page
of 34
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
May 26, 2010
Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides
Byung-Joon Kim, Jie Zhou, Bronwen Martin, et al.
ACS Pharmacology & Translational Science
|
August 10, 2019
Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury
Elliot J Glotfelty, Thomas Delgado, Luis B Tovar-Y-Romo, et al.
Journal of Neuroinflammation
|
September 13, 2016
Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
Jing-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, et al.
Plos One
|
March 3, 2012
Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis
Yazhou Li, Srinivasulu Chigurupati, Harold W Holloway, et al.
Life Sciences
|
December 29, 2004
The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats
Anne M Janas, Steven C Cunningham, Kara B Duffy, et al.
Current Alzheimer Research
|
January 11, 2018
(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease
Robert E Becker, Nigel H Greig, Debomoy K Lahiri, et al.
Frontiers in Cell and Developmental Biology
|
January 31, 2020
Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
Miaad Bader, Yazhou Li, David Tweedie, et al.
Current Medicinal Chemistry
|
April 11, 2022
Exploring the Recent Trends in Management of Dementia and Frailty: Focus on Diagnosis and Treatment
Md Mominur Rahman, Sadia Afsana Mim, Md Rezaul Islam, et al.
Frontiers in Neuroscience
|
August 28, 2020
PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease
Seong-Jin Yu, Shuchun Chen, Yung-Yung Yang, et al.
Neurobiology of Disease
|
July 12, 2019
(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice
Daniela Lecca, Miaad Bader, David Tweedie, et al.
Page
of 34
Search research articles
Search
Showing results (271-280 of 332) with videos related to
Sort By:
Page
of 34
The Journal of Pharmacology and Experimental Therapeutics
|
May 26, 2010
Transferrin fusion technology: a novel approach to prolonging biological half-life of insulinotropic peptides
Byung-Joon Kim, Jie Zhou, Bronwen Martin, et al.
ACS Pharmacology & Translational Science
|
August 10, 2019
Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury
Elliot J Glotfelty, Thomas Delgado, Luis B Tovar-Y-Romo, et al.
Journal of Neuroinflammation
|
September 13, 2016
Erratum to: Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat
Jing-Ya Wang, Ya-Ni Huang, Chong-Chi Chiu, et al.
Plos One
|
March 3, 2012
Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis
Yazhou Li, Srinivasulu Chigurupati, Harold W Holloway, et al.
Life Sciences
|
December 29, 2004
The cholinesterase inhibitor, phenserine, improves Morris water maze performance of scopolamine-treated rats
Anne M Janas, Steven C Cunningham, Kara B Duffy, et al.
Current Alzheimer Research
|
January 11, 2018
(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease
Robert E Becker, Nigel H Greig, Debomoy K Lahiri, et al.
Frontiers in Cell and Developmental Biology
|
January 31, 2020
Neuroprotective Effects and Treatment Potential of Incretin Mimetics in a Murine Model of Mild Traumatic Brain Injury
Miaad Bader, Yazhou Li, David Tweedie, et al.
Current Medicinal Chemistry
|
April 11, 2022
Exploring the Recent Trends in Management of Dementia and Frailty: Focus on Diagnosis and Treatment
Md Mominur Rahman, Sadia Afsana Mim, Md Rezaul Islam, et al.
Frontiers in Neuroscience
|
August 28, 2020
PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease
Seong-Jin Yu, Shuchun Chen, Yung-Yung Yang, et al.
Neurobiology of Disease
|
July 12, 2019
(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice
Daniela Lecca, Miaad Bader, David Tweedie, et al.
Page
of 34